# MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ

> **NCT02352883** · NA · ACTIVE_NOT_RECRUITING · sponsor: **ECOG-ACRIN Cancer Research Group** · enrollment: 368 (actual)

## Conditions studied

- Ductal Breast Carcinoma In Situ

## Interventions

- **PROCEDURE:** Magnetic Resonance Imaging
- **PROCEDURE:** Therapeutic Conventional Surgery
- **PROCEDURE:** Therapeutic Surgical Procedure
- **RADIATION:** Radiation Therapy
- **DRUG:** Endocrine Therapy
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Laboratory Biomarker Analysis
- **OTHER:** Cytology Specimen Collection Procedure

## Key facts

- **NCT ID:** NCT02352883
- **Lead sponsor:** ECOG-ACRIN Cancer Research Group
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-03-25
- **Primary completion:** 2027-11
- **Final completion:** 2027-11
- **Target enrollment:** 368 (ACTUAL)
- **Last updated:** 2025-12-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02352883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02352883, "MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02352883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*